Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Not very active against MRSA though is active in MSSA. Additionally demonstrates strong antimicrobial activity against S. pneumoniae, E. coli and H. influenzae